Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets) - EP PerMed

In the frame of the European Partnership for Personalised Medicine, EP PerMed, (supported by the European Union under Horizon Europe, Grant Agreement N° 101137129), the French National Research Agency, in collaboration with 38 funding organisations in total, launches the first joint transnational call for proposals on “Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets)”. The available budget for this call is over 45 Mio€.

The following countries (23) are participating in the call: Austria, Belgium, Denmark, Estonia, Finland, France, Germany, Hungary, Iceland, Ireland, Israel, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands and Turkiye. The following regions are participating (10): Flanders (Belgium), Walloon Region (Belgium), Wallonia-Brussels Federation (Belgium), Saxony (Germany), Lombardy (Italy), Tuscany (Italy), Azores (Portugal), Centro Region (Portugal), Catalonia (Spain) and Navarre (Spain).

Scope of the Call: The core of each application must be the identification or validation of a target for personalised medicine in combination with companion biomarker research. Consortia are required to be transnational, interdisciplinary and trans-sectoral as well as to clearly outline the personalised medicine perspective in the research proposed. EP PerMed strongly encourages the active involvement of end-users in the proposed research projects.

ANR will only fund the French partners of the selected projects. In agreement with ANR policy, funded researchers should respect the guidelines of the Nagoya protocol and consider open access publication of their results.